| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0952-7915(97)80153-7 |
| P698 | PubMed publication ID | 9039784 |
| P50 | author | Antonio Lanzavecchia | Q4776729 |
| Federica Sallusto | Q5440946 | ||
| Marina Cella | Q55278809 | ||
| P2860 | cites work | Human epidermal Langerhans cells express the high affinity receptor for immunoglobulin E (Fc epsilon RI) | Q24675347 |
| Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation | Q24677534 | ||
| Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products | Q24678867 | ||
| Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha | Q28251443 | ||
| Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset | Q28290931 | ||
| Adhesion receptors of the immune system | Q29616393 | ||
| Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor | Q29619247 | ||
| The dendritic cell system and its role in immunogenicity | Q29619870 | ||
| The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing | Q34310837 | ||
| Mechanism of suppression of cell-mediated immunity by measles virus | Q45770172 | ||
| Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. | Q54451826 | ||
| Thymic dendritic cells and T cells develop simultaneously in the thymus from a common precursor population | Q59056890 | ||
| GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells | Q59067424 | ||
| Glucocorticoids down‐regulate dendritic cell function in vitro and in vivo | Q59312658 | ||
| Dendritic cells capable of stimulating T cells in germinal centres | Q60085015 | ||
| IgE: an immunoglobulin specialized in antigen capture? | Q68439887 | ||
| Peptide-pulsed dendritic cells induce tumoricidal cytotoxic T lymphocytes from healthy donors against stably HLA-A*0201-binding peptides from the Melan-A/MART-1 self antigen | Q71420846 | ||
| Phenotypic and functional characterization of CD11c+ dendritic cell population in mouse Peyer's patches | Q71420915 | ||
| Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity | Q71563753 | ||
| Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability | Q71615065 | ||
| Targeting antigen into the phagocytic pathway in vivo induces protective tumour immunity | Q71803456 | ||
| A new foreign policy: MHC class I molecules monitor the outside world | Q34398620 | ||
| The mannose receptor and other macrophage lectins | Q35228669 | ||
| Granulocytes, macrophages, and dendritic cells arise from a common major histocompatibility complex class II-negative progenitor in mouse bone marrow | Q36215287 | ||
| Identification of proliferating dendritic cell precursors in mouse blood | Q36231236 | ||
| Antigen processing by epidermal Langerhans cells correlates with the level of biosynthesis of major histocompatibility complex class II molecules and expression of invariant chain | Q36353782 | ||
| Phagocytosis of antigens by Langerhans cells in vitro | Q36362124 | ||
| Rapid dendritic cell recruitment is a hallmark of the acute inflammatory response at mucosal surfaces | Q36363011 | ||
| The development of T and non-T cell lineages from CD34+ human thymic precursors can be traced by the differential expression of CD44. | Q36364447 | ||
| The antigen-presenting activities of Ia+ dendritic cells shift dynamically from lung to lymph node after an airway challenge with soluble antigen | Q36364695 | ||
| Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1 | Q36364968 | ||
| Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis | Q36365348 | ||
| Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity | Q36366051 | ||
| Distinct populations of dendritic cells are present in the subepithelial dome and T cell regions of the murine Peyer's patch | Q36366101 | ||
| Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines | Q36366108 | ||
| Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo | Q36366124 | ||
| Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity | Q36366130 | ||
| A life stage of particle-laden rat dendritic cells in vivo: their terminal division, active phagocytosis, and translocation from the liver to the draining lymph | Q36366346 | ||
| A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis | Q36366458 | ||
| CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha | Q36367113 | ||
| Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo | Q36367135 | ||
| High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. | Q36367196 | ||
| Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified | Q36367631 | ||
| Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures | Q36376739 | ||
| Dendritic cell development in culture from thymic precursor cells in the absence of granulocyte/macrophage colony-stimulating factor | Q36377402 | ||
| Class II major histocompatibility complex molecules of murine dendritic cells: synthesis, sialylation of invariant chain, and antigen processing capacity are down-regulated upon culture | Q37472931 | ||
| CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells | Q37698653 | ||
| Antigen-presenting cells for CD8+ T cells | Q37829524 | ||
| The endocytic activity of dendritic cells. | Q40457008 | ||
| Antigen presentation to cytotoxic T lymphocytes in vivo. | Q40468618 | ||
| CD44 splice variants: metastases meet lymphocytes | Q40490265 | ||
| Epithelial M cells: gateways for mucosal infection and immunization | Q41075139 | ||
| T cell activation determined by T cell receptor number and tunable thresholds. | Q41186277 | ||
| Class I MHC presentation of exogenous soluble antigen via macropinocytosis in bone marrow macrophages. | Q41262004 | ||
| Dendritic cells: from ontogenetic orphans to myelomonocytic descendants. | Q41266906 | ||
| Antigen presentation mediated by recycling of surface HLA-DR molecules. | Q41335304 | ||
| A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules | Q41380874 | ||
| Activation of human dendritic cells through CD40 cross-linking. | Q41440958 | ||
| Interleukin 10 inhibits T cell alloreaction induced by human dendritic cells. | Q41453118 | ||
| Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin | Q41578917 | ||
| New insights into the mobilization and phagocytic activity of dendritic cells | Q42142211 | ||
| Disappearance of certain acidic organelles (endosomes and Langerhans cell granules) accompanies loss of antigen processing capacity upon culture of epidermal Langerhans cells | Q42938806 | ||
| Ceramide inhibits antigen uptake and presentation by dendritic cells | Q42948037 | ||
| Spontaneous apoptosis of dendritic cells is efficiently inhibited by TRAP (CD40-ligand) and TNF-alpha, but strongly enhanced by interleukin-10. | Q45138741 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dendritic cell | Q506253 |
| P304 | page(s) | 10-16 | |
| P577 | publication date | 1997-02-01 | |
| P1433 | published in | Current Opinion in Immunology | Q15752917 |
| P1476 | title | Origin, maturation and antigen presenting function of dendritic cells | |
| P478 | volume | 9 |
| Q36702820 | "Spicing up" of the immune system by curcumin |
| Q52133911 | A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection. |
| Q35886800 | A correlation of measles specific antibodies and the number of plasmacytoid dendritic cells is observed after measles vaccination in 9 month old infants |
| Q40874914 | A human B-lineage dendritic cell line, HBM-noda and its potential role in human T-cell leukemia/lymphoma virus type I infection |
| Q74505824 | A modified murine local lymph node assay for the differentiation of contact photoallergy from phototoxicity by analysis of cytokine expression in skin-draining lymph node cells |
| Q30768718 | A novel adjuvant-allergen complex, CBP-rFel d 1, induces up-regulation of CD86 expression and enhances cytokine release by human dendritic cells in vitro. |
| Q50621092 | A novel potential therapy for vascular diseases: blood-derived stem/progenitor cells specifically activated by dendritic cells. |
| Q35098045 | A role for innate immunity in type 1 diabetes? |
| Q58130223 | A surface antigen of activates human monocyte-derived dendritic cells via nuclear factor-kB & p38 mitogen-activated protein kinase pathways |
| Q39561086 | AM3, a natural glycoconjugate, induces the functional maturation of human dendritic cells |
| Q36401500 | Activated murine B lymphocytes and dendritic cells produce a novel CC chemokine which acts selectively on activated T cells |
| Q39796356 | Activation of chicken bone marrow-derived dendritic cells induced by a Salmonella Enteritidis ghost vaccine candidate. |
| Q44445185 | Activation of dendritic cells by the Gal-lectin of Entamoeba histolytica drives Th1 responses in vitro and in vivo |
| Q40743107 | Activation of pulmonary and lymph node dendritic cells during chronic Pseudomonas aeruginosa lung infection in mice |
| Q34002678 | Active immunization of humans with dendritic cells |
| Q64379122 | Adenovirus-mediated CD40 ligand gene-engineered dendritic cells elicit enhanced CD8(+) cytotoxic T-cell activation and antitumor immunity |
| Q52368386 | Adipose tissue extrinsic factor: Obesity-induced inflammation and the role of the visceral lymph node. |
| Q34171636 | Adjuvant properties of thermal component of hyperthermia enhanced transdermal immunization: effect on dendritic cells |
| Q46117238 | Administration of polysaccharides from Antrodia camphorata modulates dendritic cell function and alleviates allergen-induced T helper type 2 responses in a mouse model of asthma. |
| Q63859566 | Administration of tolerogenic dendritic cells induced by interleukin-10 prolongs rat splenic allograft survival |
| Q28076866 | Advances in Molecular Imaging Strategies for In Vivo Tracking of Immune Cells |
| Q28573902 | Aging affects AO rat splenic conventional dendritic cell subset composition, cytokine synthesis and T-helper polarizing capacity |
| Q84999391 | Allergy-inducing nickel concentration is lowered by lipopolysaccharide at both the sensitization and elicitation steps in a murine model |
| Q28504672 | Altered antigen presentation in mice lacking H2-O |
| Q54567706 | Altered expression and endocytic function of CD205 in human dendritic cells, and detection of a CD205-DCL-1 fusion protein upon dendritic cell maturation. |
| Q29615498 | An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow |
| Q36401729 | An essential role for tumor necrosis factor in natural killer cell-mediated tumor rejection in the peritoneum |
| Q45731612 | An immunomodulatory protein, Ling Zhi-8, induced activation and maturation of human monocyte-derived dendritic cells by the NF-kappaB and MAPK pathways. |
| Q24806282 | Analysis of dendritic cells in tumor-free and tumor-containing sentinel lymph nodes from patients with breast cancer |
| Q73128948 | Analysis of mouse dendritic cell migration in vivo upon subcutaneous and intravenous injection |
| Q41732262 | Analysis of subcellular organelles involved in major histocompatibility complex (MHC) class II-restricted antigen presentation by electrophoresis. |
| Q36878653 | Anti-CD40 antibody and toll-like receptor 3 ligand restore dendritic cell-mediated anti-tumor immunity suppressed by morphine |
| Q36368582 | Anti-interleukin 10 receptor monoclonal antibody is an adjuvant for T helper cell type 1 responses to soluble antigen only in the presence of lipopolysaccharide |
| Q33699321 | Antigen capture, processing, and presentation by dendritic cells: recent cell biological studies. |
| Q48152286 | Antigen presentation function of brain-derived dendriform cells depends on astrocyte help |
| Q41594012 | Antigen processing differences among APC. |
| Q34156635 | Antigen traffic pathways in dendritic cells |
| Q36369028 | Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells |
| Q55457369 | Antitumor and Immunomodulatory Activities of Ganoderma lucidum Polysaccharides in Glioma-Bearing Rats. |
| Q33682531 | Apoptosis in dendritic cell biology |
| Q33661936 | Approaches to dendritic cell-based immunotherapy after peripheral blood stem cell transplantation. |
| Q35673895 | Aptamer technology for tracking cells' status & function |
| Q50798624 | Assessment of a cellular vaccination approach consisting of crawling dendritic cells (CDCs) transduced with HSV-1-Deltapac vectors. |
| Q87415924 | Association of CD1a-positive dendritic cells with papillary thyroid carcinoma in thyroid fine-needle aspirations: a cytologic and immunocytochemical evaluation |
| Q42797969 | Autoantigen-specific protection of non-obese diabetic mice from cyclophosphamide-accelerated diabetes by vaccination with dendritic cells |
| Q37087110 | B7-H1 (PD-L1) on T cells is required for T-cell-mediated conditioning of dendritic cell maturation |
| Q47733613 | Bacterial lipopolysaccharide contamination of commercial collagen preparations may mediate dendritic cell maturation in culture |
| Q36935384 | Biology of dendritic cells in aging |
| Q27028032 | Black yeasts and their filamentous relatives: principles of pathogenesis and host defense |
| Q34422852 | Boosting immune response with the invariant chain segments via association with non-peptide binding region of major histocompatibility complex class II molecules |
| Q47993508 | Bovine dendritic cells generated from monocytes and bone marrow progenitors regulate immunoglobulin production in peripheral blood B cells |
| Q36675842 | CCR2 and CCR6, but not endothelial selectins, mediate the accumulation of immature dendritic cells within the lungs of mice in response to particulate antigen. |
| Q28592208 | CCR7 ligand-enhanced phagocytosis of various antigens in mature dendritic cells-time course and antigen distribution different from phagocytosis in immature dendritic cells |
| Q44643759 | CD4+CD25+ regulatory T cells generated in response to insulin B:9-23 peptide prevent adoptive transfer of diabetes by diabetogenic T cells. |
| Q37375643 | CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy |
| Q36375919 | CD40-independent pathways of T cell help for priming of CD8(+) cytotoxic T lymphocytes |
| Q36367895 | CD8(+) T cells mediate CD40-independent maturation of dendritic cells in vivo |
| Q38207587 | Cancer Vaccines in the World of Immune Suppressive Monocytes (CD14(+)HLA-DR(lo/neg) Cells): The Gateway to Improved Responses |
| Q33717186 | Cancer gene and immunotherapy: recent developments |
| Q40469665 | Candida albicans yeast and germ tube forms interfere differently with human monocyte differentiation into dendritic cells: a novel dimorphism-dependent mechanism to escape the host's immune response. |
| Q48259593 | Characterisation of porcine monocyte-derived dendritic cells according to their cytokine profile. |
| Q54086139 | Characterization of Human Monocyte-derived Dendritic Cells by Imaging Flow Cytometry: A Comparison between Two Monocyte Isolation Protocols. |
| Q39626921 | Characterization of a profilin-like protein from Schistosoma japonicum, a potential new vaccine candidate |
| Q34006092 | Characterization of murine lung dendritic cells infected with Mycobacterium tuberculosis |
| Q38569504 | Chemical allergy: translating biology into hazard characterization |
| Q33726199 | Chemokine-mediated distribution of dendritic cell subsets in renal cell carcinoma |
| Q34002668 | Chemokines and dendritic cell traffic. |
| Q41898694 | Chlorella sorokiniana-Induced Activation and Maturation of Human Monocyte-Derived Dendritic Cells through NF-κB and PI3K/MAPK Pathways |
| Q30478815 | Choroidal dendritic cells require activation to present antigen and resident choroidal macrophages potentiate this response |
| Q42694613 | Clinical Tolerogenic Dendritic Cells: Exploring Therapeutic Impact on Human Autoimmune Disease |
| Q36235551 | Clinical trials targeting lung cancer with active immunotherapy: the scope of vaccines |
| Q78476270 | Co-stimulatory and adhesion molecules of dendritic cells in rheumatoid arthritis |
| Q54465090 | Colitogenic and non-colitogenic commensal bacteria differentially trigger DC maturation and Th cell polarization: an important role for IL-6. |
| Q88872944 | Combination of TLR8 and TLR4 agonists reduces the degrading effects of nicotine on DC-NK mediated effector T cell generation |
| Q36422849 | Combinational adenovirus-mediated gene therapy and dendritic cell vaccine in combating well-established tumors |
| Q44517198 | Combined cyclosporin-A /prednisone therapy of patients with active uveitis suppresses IFN-gamma production and the function of dendritic cells |
| Q40952104 | Comparative In Vitro and In Vivo Studies of Porcine Rotavirus G9P[13] and Human Rotavirus Wa G1P[8]. |
| Q37411209 | Comparative study of synonymous codon usage variations between the nucleocapsid and spike genes of coronavirus, and C-type lectin domain genes of human and mouse |
| Q45856627 | Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect. |
| Q39590913 | Consequences of Fas-mediated human dendritic cell apoptosis induced by measles virus. |
| Q36375909 | Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells |
| Q42005335 | Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells |
| Q34700652 | Cross-priming of cytotoxic T cells promoted by apoptosis-inducing tumor cell reactive antibodies? |
| Q36194606 | Current advances, problems and prospects for vaccine-based immunotherapy in follicular non-Hodgkin's lymphoma. |
| Q36445541 | Current progress in the development of a cell-based vaccine for the immunotherapy of acute myeloid leukemia |
| Q74086481 | Cutaneous lymphoblastic lymphoma of putative plasmacytoid dendritic cell-precursor origin: two cases |
| Q56966277 | Cytokine production and T-cell activation by macrophage-dendritic cells generated for therapeutic use |
| Q33874509 | Cytokines and chemokines in the initiation and regulation of epidermal Langerhans cell mobilization |
| Q41897237 | Cytokines regulate proteolysis in major histocompatibility complex class II-dependent antigen presentation by dendritic cells |
| Q33866265 | DC-SIGN: a guide to some mysteries of dendritic cells. |
| Q42685855 | DNA microarray analysis of the gene expression profiles of naïve versus activated tumor-specific T cells. |
| Q43963739 | DNA vaccination with AFP-encoding plasmid DNA prevents growth of subcutaneous AFP-expressing tumors and does not interfere with liver regeneration in mice |
| Q35667010 | DNA vaccines for allergy treatment |
| Q47950325 | DR non-B1 mismatches influence allogeneic MLR-induced TH1- or TH2-like cytokine responses in rhesus monkeys |
| Q47659090 | Danger signals: Chemotherapy enhancers? |
| Q39996558 | Defective dendritic cell migration and activation of adaptive immunity in PI3Kgamma-deficient mice |
| Q40668644 | Delivery of tumor-derived RNA for the induction of cytotoxic T-lymphocytes |
| Q78840786 | Dendritic cell KLH loading requirements for efficient CD4+ T-cell priming and help to peptide-specific cytotoxic T-cell response, in view of potential use in cancer vaccines |
| Q34038736 | Dendritic cell based tumor vaccines |
| Q33889300 | Dendritic cell dynamics in the liver and hepatic lymph |
| Q38114911 | Dendritic cell dysregulation during HIV-1 infection |
| Q44057652 | Dendritic cell immunotherapy for patients with metastatic renal cell carcinoma: University of Tokyo experience |
| Q34295294 | Dendritic cell lineage, plasticity and cross-regulation |
| Q37773266 | Dendritic cell preparation for immunotherapeutic interventions. |
| Q40942556 | Dendritic cell presentation of antigens from apoptotic cells in a proinflammatory context: role of opsonizing anti-beta2-glycoprotein I antibodies |
| Q73520063 | Dendritic cell vaccination for patients with chronic myelogenous leukemia |
| Q35040857 | Dendritic cell-based vaccines and therapies for cancer |
| Q35756961 | Dendritic cells and autoimmunity |
| Q35169134 | Dendritic cells and immunotherapy for cancer |
| Q34216506 | Dendritic cells and immunotherapy for malignant disease |
| Q35044785 | Dendritic cells as a tool to combat infectious diseases |
| Q34295082 | Dendritic cells as a tool to induce anergic and regulatory T cells |
| Q41649620 | Dendritic cells as adjuvants for immune-mediated resistance to tumors |
| Q47231079 | Dendritic cells derived from BCG-infected precursors induce Th2-like immune response |
| Q36368451 | Dendritic cells discriminate between yeasts and hyphae of the fungus Candida albicans. Implications for initiation of T helper cell immunity in vitro and in vivo |
| Q34280913 | Dendritic cells for specific cancer immunotherapy |
| Q41079581 | Dendritic cells generated from blood precursors of chronic myelogenous leukemia patients carry the Philadelphia translocation and can induce a CML-specific primary cytotoxic T-cell response |
| Q34430740 | Dendritic cells in cancer vaccines |
| Q33850712 | Dendritic cells in experimental allergic encephalomyelitis and multiple sclerosis |
| Q34133554 | Dendritic cells in old age--neglected by gerontology? |
| Q45881367 | Dendritic cells in patients with non-progressive B-chronic lymphocytic leukaemia have a normal functional capability but abnormal cytokine pattern |
| Q34913813 | Dendritic cells in vaccination therapies of malignant diseases |
| Q73998211 | Dendritic cells permit identification of genes encoding MHC class II-restricted epitopes of transplantation antigens |
| Q47449736 | Dendritic cells recruitment in melanoma metastasis treated by electrochemotherapy. |
| Q73311326 | Dendritic cells transfected with interleukin‐12 and pulsed with tumor extract inhibit growth of murine prostatic carcinoma in vivo |
| Q33783588 | Dendritic cells transmit human immunodeficiency virus type 1 to monocytes and monocyte-derived macrophages. |
| Q33653670 | Dendritic cells. |
| Q24792153 | Dendritic cells: In the forefront of immunopathogenesis and vaccine development - A review |
| Q33541967 | Dendritic cells: a link between innate and adaptive immunity |
| Q33541092 | Dendritic cells: a novel therapeutic modality |
| Q33762520 | Dendritic cells: the driving force behind autoimmunity in rheumatoid arthritis? |
| Q81433493 | Dendritic cells: what do they do? |
| Q35552591 | Development of HPV Vaccines for HPV-associated Head and Neck Squamous Cell Carcinoma |
| Q50119612 | Developmental control of endocytosis in dendritic cells by Cdc42. |
| Q36780661 | Developmental dissociation of thymic dendritic cell and thymocyte lineages revealed in growth factor receptor mutant mice |
| Q35940181 | Developmental plasticity of CNS microglia |
| Q47872621 | Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells. |
| Q58292878 | Different way of LMP/TAP/MHC gene clustering in vertebrates, viviparity and anti‐tumor immunity failure |
| Q34613581 | Differential expression of Toll-like receptors in dendritic cells of patients with dengue during early and late acute phases of the disease |
| Q57209328 | Differential expression of alternative H2-M isoforms in B cells, dendritic cells and macrophages by proinflammatory cytokines |
| Q57371125 | Differential post-translational modification of CD63 molecules during maturation of human dendritic cells |
| Q79160660 | Differential role of mitogen-activated protein kinases in CD40-mediated IL-12 production by immature and mature dendritic cells |
| Q60687729 | Differentiation of monocyte-derived dendritic cells is associated with upregulation and activation of Rac-1 small GTPase |
| Q72998296 | Differentiation of porcine dendritic cells by granulocyte-macrophage colony-stimulating factor expressed in Pichia pastoris |
| Q43552559 | Diltiazem downregulates IL-12 production by human dendritic cells |
| Q44033294 | Diltiazem impairs maturation and functions of human dendritic cells |
| Q53198630 | Donor dendritic cell proliferation and migration in hepatic allografts by pretransplant intraportal infusion of recipient blood into donor rats. |
| Q38735296 | Down-regulation of RBP-J mediated by microRNA-133a suppresses dendritic cells and functions as a potential tumor suppressor in osteosarcoma |
| Q74319214 | Dysfunctional regulation of the development of monocyte-derived dendritic cells in cancer patients |
| Q73205992 | Early events in dendritic cell maturation induced by LPS |
| Q37885432 | Educational case series: Mechanisms of drug allergy. |
| Q36945772 | Effect of chronic morphine administration on circulating dendritic cells in SIV-infected rhesus macaques |
| Q36164524 | Effect of tyrosine kinase inhibition using imatinib on normal lymphohematopoietic cells. |
| Q42501639 | Efficient gene transduction by RGD-fiber modified recombinant adenovirus into dendritic cells |
| Q77068370 | Efficient generation of dendritic cells from alveolar and pleural macrophages as well as blood monocytes in patients with lung cancer |
| Q36401207 | Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells |
| Q45881751 | Electroporation of immature and mature dendritic cells: implications for dendritic cell-based vaccines |
| Q37404099 | Elements Involved In Promoting Eosinophilic Gastrointestinal Disorders |
| Q42798992 | Engineered fusion hybrid vaccine of IL-4 gene-modified myeloma and relative mature dendritic cells enhances antitumor immunity |
| Q64378543 | Enhanced HER-2/neu-specific antitumor immunity by cotransduction of mouse dendritic cells with two genes encoding HER-2/neu and alpha tumor necrosis factor |
| Q78157760 | Enhanced antigen-presenting activity and tumour necrosis factor-alpha-independent activation of dendritic cells following treatment with Mycobacterium bovis bacillus Calmette-Guérin |
| Q45862359 | Enhanced local dendritic cell activity and tumor-specific immunoresponse in combined radiofrequency ablation and interleukin-2 for the treatment of human head and neck cancer in a murine orthotopic model |
| Q40661349 | Enhancing antitumor by immunization with fusion of dendritic cells and engineered tumor cells |
| Q34435050 | Enterovirus-71 virus-like particles induce the activation and maturation of human monocyte-derived dendritic cells through TLR4 signaling |
| Q36193377 | Equine dendritic cells generated with horse serum have enhanced functionality in comparison to dendritic cells generated with fetal bovine serum |
| Q53309059 | Escherichia coli K1 Promotes the Ligation of CD47 with Thrombospondin-1 To Prevent the Maturation of Dendritic Cells in the Pathogenesis of Neonatal Meningitis |
| Q36369156 | Essential role of lymph nodes in contact hypersensitivity revealed in lymphotoxin-alpha-deficient mice. |
| Q44149897 | Estrogen inhibition of EAE involves effects on dendritic cell function. |
| Q24800882 | Evaluation of dendritic cells loaded with apoptotic cancer cells or expressing tumour mRNA as potential cancer vaccines against leukemia |
| Q44478566 | Evidence for the immunosuppressive role of nicotine on human dendritic cell functions |
| Q38693287 | Evolution, Development, and Function of the Pulmonary Surfactant System in Normal and Perturbed Environments. |
| Q47595661 | Ex vivo enhancement of antigen-presenting function of dendritic cells and its application for DC-based immunotherapy |
| Q34450592 | Exogenous addition of arachidonic acid to the culture media enhances the functionality of dendritic cells for their possible use in cancer immunotherapy |
| Q42380131 | Expression and Functional Role of α7 Nicotinic Receptor in Human Cytokine-stimulated Natural Killer (NK) Cells |
| Q73883192 | Expression of Fc receptors for IgG during acute and chronic cutaneous inflammation in atopic dermatitis |
| Q73589578 | Expression of authentic substance P receptors in murine and human dendritic cells |
| Q77647400 | Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases define the migratory characteristics of human monocyte-derived dendritic cells |
| Q74484209 | Expression of maturation-/migration-related molecules on human dendritic cells from blood and skin |
| Q73264792 | Extensive characterization of the immunophenotype and pattern of cytokine production by distinct subpopulations of normal human peripheral blood MHC II+/lineage- cells |
| Q36780502 | Extracellular antigen processing and presentation by immature dendritic cells |
| Q22254637 | FDF03, a novel inhibitory receptor of the immunoglobulin superfamily, is expressed by human dendritic and myeloid cells |
| Q73109707 | Factor XIIIa positive dendritic cells are a major accessory cell population in the elicitation phase of DNCB-induced contact hypersensitivity |
| Q45736630 | Factors influencing cross-presentation of non-self antigens expressed from recombinant adeno-associated virus vectors |
| Q24802149 | Flow cytometric assessment of the reactivity of a panel of monoclonal antibodies (mAb) against two populations of human dendritic cells (DC) |
| Q77394157 | From sentinel to messenger: an extended phenotypic analysis of the monocyte to dendritic cell transition |
| Q37266023 | Fully competent dendritic cells as inducers of T cell anergy in autoimmunity |
| Q77608031 | Fully mobilizing host defense: building better vaccines |
| Q49332446 | Functional Relevance of Macrophage-mediated Inflammation to Cardiac Regeneration |
| Q40809425 | Functional and phenotypic characterization of distinct porcine dendritic cells derived from peripheral blood monocytes |
| Q80533530 | Functional and structural characterization of two populations of human monocyte-derived dendritic cells |
| Q40577996 | Functional impairment of dendritic cells caused by murine hepatocellular carcinoma |
| Q40663692 | Gallium arsenide exposure impairs splenic B cell accessory function |
| Q73173535 | Ganglioside GD1a impedes lipopolysaccharide-induced maturation of human dendritic cells |
| Q35886513 | Gene expression profiles identify both MyD88-independent and MyD88-dependent pathways involved in the maturation of dendritic cells mediated by heparan sulfate: a novel adjuvant |
| Q28481435 | Gene expression profiling of dendritic cells in different physiological stages under Cordyceps sinensis treatment |
| Q35951663 | Gene induction during differentiation of human monocytes into dendritic cells: an integrated study at the RNA and protein levels |
| Q45175374 | Generalized eruptive histiocytoma |
| Q37423250 | Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus |
| Q36805906 | Generation and maturation of bone marrow-derived DCs under serum-free conditions |
| Q37173478 | Generation in vivo of peptide-specific cytotoxic T cells and presence of regulatory T cells during vaccination with hTERT (class I and II) peptide-pulsed DCs. |
| Q40643454 | Generation of CD8+ cytotoxic T lymphocytes against breast cancer cells by stimulation with mammaglobin-A-pulsed dendritic cells. |
| Q81203154 | Generation of dendritic cells from rabbit bone marrow mononuclear cell cultures supplemented with hGM-CSF and hIL-4 |
| Q40836596 | Generation of functionally mature dendritic cells from the multipotential stem cell line FDCP-mix |
| Q46830804 | Generation of in vitro B-CLL specific HLA class I restricted CTL responses using autologous dendritic cells pulsed with necrotic tumor lysate |
| Q42972766 | Generation of interferon alpha-producing predendritic cell (Pre-DC)2 from human CD34(+) hematopoietic stem cells |
| Q40709370 | Generation of large numbers of dendritic cells in a closed system using Cell Factories. |
| Q56966464 | Generation of phagocytic MAK and MAC-DC for therapeutic use |
| Q85054741 | Generation of self‐renewing immature dendritic cells from mouse spleen that can take up mycobacteria and present antigens to T cells |
| Q34452039 | Genetically modified tumour vaccines: an obstacle race to break host tolerance to cancer |
| Q36861228 | Ginsenoside Rp1 Exerts Anti-inflammatory Effects via Activation of Dendritic Cells and Regulatory T Cells |
| Q60998394 | Granulocyte-macrophage colony-stimulating factor induces a unique set of STAT factors in murine dendritic cells |
| Q33867263 | Gut Microbiota Co-microevolution with Selection for Host Humoral Immunity |
| Q41785343 | Hepatitis C virus modulates human monocyte-derived dendritic cells |
| Q38990675 | High-Intensity Focused Ultrasound- and Radiation Therapy-Induced Immuno-Modulation: Comparison and Potential Opportunities |
| Q39527075 | Honokiol inhibits LPS-induced maturation and inflammatory response of human monocyte-derived dendritic cells. |
| Q57295207 | Human Dendritic Cells: Ontogeny and Their Subsets in Health and Disease |
| Q42661062 | Human NK cells directly recognize Mycobacterium bovis via TLR2 and acquire the ability to kill monocyte-derived DC. |
| Q41096075 | Human dendritic cell responses to lipopolysaccharide and CD40 ligation are differentially regulated by interleukin-10. |
| Q36354718 | Human dendritic cell subsets for vaccination |
| Q73711216 | Human dendritic cells in the severe combined immunodeficiency mouse model: their potentiating role in the allergic reaction |
| Q33645462 | Human immunodeficiency virus type 1 derived from cocultures of immature dendritic cells with autologous T cells carries T-cell-specific molecules on its surface and is highly infectious. |
| Q40108552 | Human monocytoid THP-1 cell line versus monocyte-derived human immature dendritic cells as in vitro models for predicting the sensitising potential of chemicals |
| Q45879284 | Human myeloid dendritic cells transduced with an adenoviral interleukin-10 gene construct inhibit human skin graft rejection in humanized NOD-scid chimeric mice |
| Q43883899 | Hyaluronic acid and chondroitin sulphate A rapidly promote differentiation of immature DC with upregulation of costimulatory and antigen-presenting molecules, and enhancement of NF-kappaB and protein kinase activity |
| Q36849152 | IFN-alpha and novel strategies of combination therapy for cancer |
| Q74684904 | IL-10 alters DC function via modulation of cell surface molecules resulting in impaired T-cell responses |
| Q49467068 | IL-10 in the microenvironment of HNSCC inhibits the CpG ODN induced IFN-α secretion of pDCs |
| Q77332311 | IL-15-induced conversion of monocytes to mature dendritic cells |
| Q73341494 | IL-4 induces the intracellular expression of the alpha chain of the high-affinity receptor for IgE in in vitro-generated dendritic cells |
| Q24803671 | Identification of proteases employed by dendritic cells in the processing of protein purified derivative (PPD) |
| Q47165111 | Immethridine, histamine H3-receptor (H3R) agonist, alleviated experimental autoimmune encephalomyelitis via inhibiting the function of dendritic cells |
| Q40955563 | Immortalized cell lines derived from mice lacking both type I and type II IFN receptors unify some functions of immature and mature dendritic cells |
| Q34361474 | Immune escape of gliomas. |
| Q39147683 | Immune modulation by dendritic-cell-based cancer vaccines |
| Q44798815 | Immune response in cervical lymph nodes from patients with primary oral squamous cell carcinoma |
| Q34700675 | Immune suppression in head and neck cancers: a review |
| Q35628183 | Immune-enhancing effect of nano-DNA vaccine encoding a gene of the prME protein of Japanese encephalitis virus and BALB/c mouse granulocyte-macrophage colony-stimulating factor |
| Q26777195 | Immunity to Pathogens Taught by Specialized Human Dendritic Cell Subsets |
| Q42210903 | Immunization with adenovirus LIGHT-engineered dendritic cells induces potent T cell responses and therapeutic immunity in HBV transgenic mice |
| Q38790788 | Immunogenicity of oncolytic vaccinia viruses JX-GFP and TG6002 in a human melanoma in vitro model: studying immunogenic cell death, dendritic cell maturation and interaction with cytotoxic T lymphocytes |
| Q26827675 | Immunological cells and functions in Gaucher disease |
| Q33899097 | Immunology and immunotherapy of human cancer: present concepts and clinical developments |
| Q37163123 | Immunology of dermatophytosis. |
| Q74181214 | Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity |
| Q40252849 | Immunostimulating factor isolated from actinobacillus actinomycetemcomitans stimulates monocytes and inflammatory macrophages |
| Q41065287 | Immunostimulatory DNA: sequence-dependent production of potentially harmful or useful cytokines |
| Q64097592 | Immunostimulatory nanomedicines synergize with checkpoint blockade immunotherapy to eradicate colorectal tumors |
| Q84991259 | Immunosuppressive Effect of Cordyceps CS-4 on Human Monocyte-Derived Dendritic Cellsin Vitro |
| Q34707494 | Immunotherapy of prostate cancer |
| Q37771485 | Impact of aging on dendritic cell functions in humans |
| Q30448571 | Impaired accessory cell function in a human dendritic cell line after human immunodeficiency virus infection |
| Q36375533 | In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas. |
| Q45889330 | In vitro activation of cancer patient-derived dendritic cells by tumor cells genetically modified to express CD154. |
| Q44488460 | In vitro analysis of the antileukemic effect of tumor necrosis factor-alpha gene therapy with myeloid progenitor cells: the role of dendritic cells |
| Q27481382 | In vitro atrazine exposure affects the phenotypic and functional maturation of dendritic cells |
| Q35910887 | In vitro expansion of erythroid progenitors from polycythemia vera patients leads to decrease in JAK2 V617F allele |
| Q28347565 | In vitro generation of human CD86+ dendritic cells from CD34+ haematopoietic progenitors by PMA and in serum-free medium |
| Q73174279 | In vitro immunization of patient T cells with autologous bone marrow antigen presenting cells pulsed with tumor lysates |
| Q83731500 | In vitro-induced response patterns of antileukemic T cells: characterization by spectratyping and immunophenotyping |
| Q46054318 | Inability to induce tolerance through direct antigen presentation |
| Q54348110 | Inclusive estimation of complex antigen presentation functions of monocyte-derived dendritic cells differentiated under normoxia and hypoxia conditions. |
| Q35635302 | Incorporation of glycosylphosphatidylinositol-anchored granulocyte- macrophage colony-stimulating factor or CD40 ligand enhances immunogenicity of chimeric simian immunodeficiency virus-like particles |
| Q47744165 | Increased expression of CD86 and reduced production of IL-12 and IL-10 by monocyte-derived dendritic cells from allergic asthmatics and their effects on Th1- and Th2-type cytokine balance |
| Q43683213 | Induction of CD4+ CD25+ Foxp3+ T regulatory cells by dendritic cells derived from ILT3 lentivirus-transduced human CD34+ cells |
| Q33776098 | Induction of CD8+ T cells using heterologous prime-boost immunisation strategies |
| Q40639503 | Induction of Influenza Matrix Protein 1 and MelanA-specific T lymphocytes in vitro using mRNA-electroporated dendritic cells |
| Q42944333 | Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells |
| Q40940347 | Induction of intracellular arginase activity does not diminish the capacity of macrophages to produce nitric oxide in vitro. |
| Q33340683 | Induction of maturation and activation of human dendritic cells: a mechanism underlying the beneficial effect of Viscum album as complimentary therapy in cancer |
| Q33835167 | Induction of polyomavirus-specific CD8(+) T lymphocytes by distinct dendritic cell subpopulations |
| Q73166228 | Induction of the IL-10 gene via the fas receptor in monocytes--an anti-inflammatory mechanism in the absence of apoptosis |
| Q40595863 | Induction of various immune modulatory molecules in CD34(+) hematopoietic cells. |
| Q73457727 | Infants colonized with enterotoxin-producing staphylococci at 3 months display a decreased frequency of interferon-gamma-producing CD45RO lymphocytes upon stimulation with staphylococcal enterotoxin A at birth but not at 6 months of age |
| Q33813011 | Infection of human dendritic cells by a sindbis virus replicon vector is determined by a single amino acid substitution in the E2 glycoprotein |
| Q34693296 | Inflammatory cytokines and antigen presenting cell activation |
| Q46401357 | Influence of interleukin-4 on the phenotype and function of bone marrow-derived murine dendritic cells generated under serum-free conditions |
| Q40267847 | Influenza virus evades innate and adaptive immunity via the NS1 protein |
| Q42972688 | Inhibition of CD83 cell surface expression during dendritic cell maturation by interference with nuclear export of CD83 mRNA. |
| Q43577773 | Inhibition of effects of endogenously synthesized histamine disturbs in vitro human dendritic cell differentiation |
| Q42971997 | Inhibition of vascular endothelial growth factor by small interfering RNA upregulates differentiation, maturation and function of dendritic cells |
| Q47627609 | Innate Immune Response of the Pig Laryngeal Mucosa to Endotracheal Intubation |
| Q34339797 | Innate and adaptive immune responses in male and female reproductive tracts in homeostasis and following HIV infection |
| Q48093365 | Innate control of actin nucleation determines two distinct migration behaviours in dendritic cells. |
| Q34007420 | Interaction of dendritic cells with mycobacteria: where the action starts |
| Q34568695 | Interferon-alpha in tumor immunity and immunotherapy |
| Q33381621 | Interferon-beta pretreatment of conventional and plasmacytoid human dendritic cells enhances their activation by influenza virus |
| Q56943358 | Interleukin-10 increases mannose receptor expression and endocytic activity in monocyte-derived dendritic cells |
| Q33844708 | Interleukin-1beta in immune cells of the abdominal vagus nerve: a link between the immune and nervous systems? |
| Q27301176 | Intestinal colonization of IL-2 deficient mice with non-colitogenic B. vulgatus prevents DC maturation and T-cell polarization |
| Q35829642 | Intracerebral recruitment and maturation of dendritic cells in the onset and progression of experimental autoimmune encephalomyelitis |
| Q42798836 | Intratumoral administration of immature dendritic cells following the adenovirus vector encoding CD40 ligand elicits significant regression of established myeloma |
| Q78298259 | Involvement of LOX-1 in dendritic cell-mediated antigen cross-presentation |
| Q35946403 | Involvement of dendritic cells in autoimmune diseases in children |
| Q37350865 | Is there a feudal hierarchy amongst regulatory immune cells? More than just Tregs |
| Q73035410 | Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells |
| Q33864114 | Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization |
| Q42155780 | Legionella pneumophila infection up-regulates dendritic cell Toll-like receptor 2 (TLR2)/TLR4 expression and key maturation markers |
| Q45871804 | Lentivectors are efficient tools to manipulate the dendritic cell cytoskeleton |
| Q51374094 | Leukaemia-derived dendritic cells can be generated from blood or bone marrow cells from patients with myelodysplasia: a methodological approach under serum-free culture conditions. |
| Q51374087 | Leukemia-derived dendritic cells can be generated from blood or bone marrow cells from patients with acute myeloid leukaemia: a methodological approach under serum-free culture conditions. |
| Q46898682 | Levamisole enhances immune response by affecting the activation and maturation of human monocyte-derived dendritic cells |
| Q78825303 | Linomide inhibits insulitis and modulates cytokine production in pancreatic islets in the nonobese diabetic mouse |
| Q40220180 | Lipopolysaccharide promotes and augments metal allergies in mice, dependent on innate immunity and histidine decarboxylase. |
| Q44290945 | Liposomal delivery of antigen to human dendritic cells |
| Q41603393 | Listeria monocytogenes in laboratory mice: a model of short-term infectious and pathogenic processes controllable by regulated protective immune responses |
| Q38351525 | Lovastatin inhibits bone marrow-derived dendritic cell maturation and upregulates proinflammatory cytokine production |
| Q56905624 | Low concentrations of lipopolysaccharide synergize with peptides to augment human T-cell proliferation and can prevent the induction of non-responsiveness by CTLA4-Ig |
| Q90248463 | Low-Dose Gemcitabine Treatment Enhances Immunogenicity and Natural Killer Cell-Driven Tumor Immunity in Lung Cancer |
| Q38516370 | Lycopene suppresses the lipopolysaccharide-induced phenotypic and functional maturation of murine dendritic cells through inhibition of mitogen-activated protein kinases and nuclear factor-kappaB. |
| Q33957690 | MHC class II-restricted antigen processing and presentation |
| Q34006887 | Major histocompatibility complex class II-independent generation of neutralizing antibodies against T-cell-dependent Borrelia burgdorferi antigens presented by dendritic cells: regulation by NK and gammadelta T cells |
| Q37331842 | Manipulation of dendritic cell functions by human cytomegalovirus |
| Q36061998 | Mannosylated biodegradable polyethyleneimine for targeted DNA delivery to dendritic cells. |
| Q38008359 | Mast cell synapses and exosomes: membrane contacts for information exchange |
| Q61053890 | Maturation of DC is associated with changes in motile characteristics and adherence |
| Q36380589 | Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells |
| Q34236194 | Met protein and hepatocyte growth factor (HGF) in papillary carcinoma of the thyroid: evidence for a pathogenetic role in tumourigenesis |
| Q38784095 | Metastatic melanoma secreted IL-10 down-regulates CD1 molecules on dendritic cells in metastatic tumor lesions |
| Q38066148 | Micro and nanoparticle-based delivery systems for vaccine immunotherapy: an immunological and materials perspective |
| Q24647119 | MicroRNA-155 modulates the pathogen binding ability of dendritic cells (DCs) by down-regulation of DC-specific intercellular adhesion molecule-3 grabbing non-integrin (DC-SIGN) |
| Q43743630 | Microarray analysis of differentially expressed genes from Peyer's patches of cattle orally challenged with bovine spongiform encephalopathy. |
| Q28214390 | Molecular and functional characterization of human Dectin-1 |
| Q51827105 | Monocyte-derived dendritic cells from patients with severe forms of chromoblastomycosis induce CD4+ T cell activation in vitro. |
| Q35210402 | Monocyte-derived dendritic cells in chronic lymphocytic leukemia |
| Q30975460 | Morphologic and immunohistochemical features of experimentally induced allergic contact dermatitis in Göttingen minipigs |
| Q37648949 | Multimodality Imaging of Bone Marrow-Derived Dendritic Cell Migration and Antitumor Immunity |
| Q37122974 | Mycobacteria and innate cells: critical encounter for immunogenicity |
| Q41195683 | Mycobacterium tuberculosis diverts alpha interferon-induced monocyte differentiation from dendritic cells into immunoprivileged macrophage-like host cells |
| Q64118724 | Myosin II Activity Is Selectively Needed for Migration in Highly Confined Microenvironments in Mature Dendritic Cells |
| Q43625707 | NK cell-mediated lysis of autologous antigen-presenting cells is triggered by the engagement of the phosphatidylinositol 3-kinase upon ligation of the natural cytotoxicity receptors NKp30 and NKp46. |
| Q42058394 | NOD2 stimulation by Staphylococcus aureus-derived peptidoglycan is boosted by Toll-like receptor 2 costimulation with lipoproteins in dendritic cells |
| Q38054112 | Nanovectorized radiotherapy: a new strategy to induce anti-tumor immunity |
| Q38532047 | Nasobronchial interaction |
| Q33878894 | Natural adjuvants: endogenous activators of dendritic cells |
| Q39765877 | Neem leaf glycoprotein matures myeloid derived dendritic cells and optimizes anti-tumor T cell functions |
| Q34319935 | Neighborhood politics: the immunoregulatory function of organ-resident liver endothelial cells. |
| Q39583017 | Neutralizing monoclonal antibodies block human immunodeficiency virus type 1 infection of dendritic cells and transmission to T cells. |
| Q42971524 | Neutrophil granulocyte-committed cells can be driven to acquire dendritic cell characteristics. |
| Q48349888 | Neutrophils secreting tumor necrosis factor alpha infiltrate the central nervous system of BALB/c mice with experimental autoimmune encephalomyelitis |
| Q38862432 | Newcastle disease virus-like particles induce dendritic cell maturation and enhance viral-specific immune response |
| Q33883311 | Nontoxic Shiga toxin derivatives from Escherichia coli possess adjuvant activity for the augmentation of antigen-specific immune responses via dendritic cell activation |
| Q36368519 | Notch1 deficiency dissociates the intrathymic development of dendritic cells and T cells. |
| Q79186748 | Novel and Detrimental Effects of Lipopolysaccharide on In Vitro Generation of Immature Dendritic Cells: Involvement of Mitogen-Activated Protein Kinase p38 |
| Q40762186 | Oral DNA vaccination: antigen uptake and presentation by dendritic cells elicits protective immunity |
| Q42806821 | Ox40-ligand has a critical costimulatory role in dendritic cell:T cell interactions |
| Q48681818 | Oxidative stress and cellular pathways of asthma and inflammation: Therapeutic strategies and pharmacological targets |
| Q44300358 | PI3K-γ inhibition ameliorates acute lung injury through regulation of IκBα/NF-κB pathway and innate immune responses |
| Q35809825 | Papillary carcinoma of the thyroid: hepatocyte growth factor (HGF) stimulates tumor cells to release chemokines active in recruiting dendritic cells |
| Q35582660 | Paracoccidioides brasiliensis interferes on dendritic cells maturation by inhibiting PGE2 production |
| Q43760306 | Peroxisome proliferator-activated receptor gamma activators affect the maturation of human monocyte-derived dendritic cells |
| Q57244326 | Peroxisome proliferator-activated receptor γ activators inhibit interleukin-12 production in murine dendritic cells |
| Q74552624 | Peyer's patch dendritic cells and the induction of mucosal immune responses |
| Q30834800 | Phage antibodies against human dendritic cell subpopulations obtained by flow cytometry-based selection on freshly isolated cells |
| Q33683408 | Phagocytic antigen processing and effects of microbial products on antigen processing and T-cell responses |
| Q78596431 | Phagocytosis of bacille Calmette-Guérin-infected necrotic macrophages induces a maturation phenotype and evokes antigen-presentation functions in dendritic cells |
| Q44433515 | Phenotype and Function of Murine Discrete Peyer's Patch Macrophage Derived-Dendritic Cells |
| Q34426914 | Phenotypic and functional characteristics of dendritic cells derived from human peripheral blood monocytes |
| Q34320970 | Physiological and molecular determinants of embryo implantation |
| Q34391501 | Plexin-B2 and Plexin-D1 in dendritic cells: expression and IL-12/IL-23p40 production |
| Q40217887 | Poly-L-lysine-coated nanoparticles: a potent delivery system to enhance DNA vaccine efficacy |
| Q39632514 | Polybacterial challenge enhances HIV reactivation in latently infected macrophages and dendritic cells |
| Q24336346 | Polymerase chain reaction selects a novel disintegrin proteinase from CD40-activated germinal center dendritic cells |
| Q32123574 | Polymerase chain reaction-based identification of a novel serpin from human dendritic cells. |
| Q46491194 | Polysaccharide purified from Ganoderma lucidum induced activation and maturation of human monocyte-derived dendritic cells by the NF-kappaB and p38 mitogen-activated protein kinase pathways. |
| Q57449379 | Poor In Vitro Maturation and Pro-Inflammatory Cytokine Response of Dendritic Cells in Children at Genetic Risk of Type 1 Diabetes |
| Q34010283 | Positive and negative aspects of the human immunodeficiency virus protease: development of inhibitors versus its role in AIDS pathogenesis |
| Q46249994 | Post-transcriptional regulation of adapter molecules by IL-10 inhibits TLR-mediated activation of antigen-presenting cells |
| Q33921487 | Preparation of triple-negative breast cancer vaccine through electrofusion with day-3 dendritic cells |
| Q36580586 | Present and future of lung cancer vaccines |
| Q35132041 | Pro-inflammatory, Th1, Th2, Th17 cytokines and dendritic cells: a cross-sectional study in chronic periodontitis |
| Q35872091 | Probiotic modulation of dendritic cells co-cultured with intestinal epithelial cells |
| Q33578067 | Production of TGF-beta1 as a Mechanism for Defective Antigen-presenting Cell Function of Macrophages Generated in vitro with M-CSF. |
| Q73351353 | Professional antigen presenting cells in minor salivary glands in Sjögren's syndrome: potential contribution to the histopathological diagnosis? |
| Q35922431 | Progress in the development of immunotherapy of cancer using ex vivo-generated dendritic cells expressing multiple tumor antigen epitopes. |
| Q35646910 | Prolonged expression of MHC class I - peptide expression in bone marrow derived retrovirus transfected matured dendritic cells by continuous centrifugation in the presence of IL-4. |
| Q35784239 | Prospects for dendritic cell vaccination in persistent infection with hepatitis C virus |
| Q54671907 | Prostaglandin D2 affects the differentiation and functions of human dendritic cells: impact on the T cell response. |
| Q42079617 | Prostaglandin E2 and tumor necrosis factor alpha cooperate to activate human dendritic cells: synergistic activation of interleukin 12 production |
| Q35084902 | Protection against experimental autoimmune myocarditis is mediated by interleukin-10-producing T cells that are controlled by dendritic cells |
| Q40625451 | Protection of pigs against classical swine fever with DNA-delivered gp55. |
| Q34129094 | Protection of rhesus macaques against lethal Plasmodium knowlesi malaria by a heterologous DNA priming and poxvirus boosting immunization regimen |
| Q28612038 | Proteolysis and antigen presentation by MHC class II molecules |
| Q41844970 | Pulsing with blast cell lysate or blast-derived total RNA reverses the dendritic cell-mediated cytotoxic activity of cytokine-induced killer cells against allogeneic acute myelogenous leukemia cells |
| Q40722726 | Purinergic mechanism in the immune system: A signal of danger for dendritic cells. |
| Q78593977 | Quantitative analysis of the antigen-specific IFNgamma+ T cell-mediated immune response in conventional outbred pigs: kinetics and duration of the DNA-induced IFNgamma+ CD8+ T cell response |
| Q36368041 | Quo vadis haemapheresis. Current developments in haemapheresis |
| Q80499626 | RIP2 mediates LPS-induced p38 and IkappaBalpha signaling including IL-12 p40 expression in human monocyte-derived dendritic cells |
| Q52166799 | Rac is required for constitutive macropinocytosis by dendritic cells but does not control its downregulation. |
| Q33855405 | Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells. |
| Q73416968 | Rat bone marrow-derived dendritic cells, but not ex vivo dendritic cells, secrete nitric oxide and can inhibit T-cell proliferation |
| Q39985946 | Rationalizing the use of functionalized poly-lactic-co-glycolic acid nanoparticles for dendritic cell-based targeted anticancer therapy. |
| Q35209997 | Recent advances in the discovery and delivery of vaccine adjuvants |
| Q37699345 | Recent advances on the immunomodulatory effects of IFN-alpha: implications for cancer immunotherapy and autoimmunity. |
| Q36739751 | Regulatory polymorphisms modulate the expression of HLA class II molecules and promote autoimmunity. |
| Q35292814 | RelB nuclear translocation regulates B cell MHC molecule, CD40 expression, and antigen-presenting cell function. |
| Q40384194 | Release of IL-1beta via IL-1beta-converting enzyme in a skin dendritic cell line exposed to 2,4-dinitrofluorobenzene |
| Q30501320 | Release of endogenous danger signals from HIFU-treated tumor cells and their stimulatory effects on APCs. |
| Q34004618 | Remnants of suicidal cells fostering systemic autoaggression. Apoptosis in the origin and maintenance of autoimmunity |
| Q89547044 | Resident Memory B Cells |
| Q47741693 | Respiratory sensitization: toxicological point of view on the available assays |
| Q36401161 | Resting respiratory tract dendritic cells preferentially stimulate T helper cell type 2 (Th2) responses and require obligatory cytokine signals for induction of Th1 immunity |
| Q40943680 | Revision of the functional analysis and structural features of immortalized dendritic cell lines derived from mice lacking both type I and type II interferon receptors |
| Q34327387 | Rhabdovirus-based vectors with human immunodeficiency virus type 1 (HIV-1) envelopes display HIV-1-like tropism and target human dendritic cells |
| Q85933520 | Role of growth hormone in maturation and activation of dendritic cells via miR-200a and the Keap1/Nrf2 pathway |
| Q35855829 | Role of surfactant protein A in the innate host defense and autoimmunity |
| Q56787459 | Role of the influenza virus nonstructural 1 protein in evasion of immunity |
| Q24675023 | Roles of antimicrobial peptides such as defensins in innate and adaptive immunity |
| Q24296666 | SPPL2a and SPPL2b promote intramembrane proteolysis of TNFalpha in activated dendritic cells to trigger IL-12 production |
| Q50126606 | Salmonella efficiently enter and survive within cultured CD11c+ dendritic cells initiating cytokine expression. |
| Q40507112 | Salmonella enterica serovar Typhimurium interaction with dendritic cells: impact of the sifA gene |
| Q35747474 | Sampling tumor-draining lymph nodes for phenotypic and functional analysis of dendritic cells and T cells |
| Q58843220 | Selective maturation of dendritic cells byNippostrongylus brasiliensis-secreted proteins drives Th2 immune responses |
| Q42971765 | Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites |
| Q36939594 | Sensors of ionizing radiation effects on the immunological microenvironment of cancer |
| Q33943427 | Shaping and tuning of the chemokine system by regulation of receptor expression and signaling: dendritic cells as a paradigm. |
| Q34478042 | Soluble CD40 ligand-activated human peripheral B cells as surrogated antigen presenting cells: A preliminary approach for anti-HBV immunotherapy |
| Q51125668 | Specificity and efficacy of dendritic cell-based vaccination against tuberculosis with complex mycobacterial antigens in a mouse model. |
| Q36978792 | Sphingosine 1-phosphate as a novel immune regulator of dendritic cells |
| Q34006917 | Stimulation of dendritic cells via CD40 enhances immune responses to Mycobacterium tuberculosis infection. |
| Q34560527 | Studies on CD4 T cell immunity using somatic transgene immunization |
| Q36376628 | Subcapsular sinus macrophages limit acute gammaherpesvirus dissemination |
| Q44294573 | Superoxide anions induce the maturation of human dendritic cells |
| Q84578008 | Suppressive effect of aqueous humor on lipopolysaccharide-induced dendritic cell maturation |
| Q56655895 | Surfactant protein D enhances bacterial antigen presentation by bone marrow-derived dendritic cells |
| Q34972916 | Synthetic peptides as cancer vaccines |
| Q52018818 | T cell signaling mechanisms that regulate HIV-1 infection. |
| Q33774232 | T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal |
| Q53885791 | T-helper cell-response to MHC class II-binding peptides of the renal cell carcinoma-associated antigen RAGE-1. |
| Q24309326 | TECK: a novel CC chemokine specifically expressed by thymic dendritic cells and potentially involved in T cell development |
| Q36368029 | TRANCE, a tumor necrosis factor family member critical for CD40 ligand-independent T helper cell activation |
| Q34588561 | Targeting vaccines to dendritic cells |
| Q58479185 | The DC-SIGNR 7/5 Genotype is Associated with High Dendritic Cell Counts and Their Subsets in Patients Infected with HIV-1 |
| Q92318457 | The Deubiquitinase Inhibitor b-AP15 and Its Effect on Phenotype and Function of Monocyte-Derived Dendritic Cells |
| Q37311022 | The Use of In Vitro Systems for Evaluating Immunotoxicity: The Report and Recommendations of an ECVAM Workshop |
| Q40788843 | The comparative efficacy of CTLA-4 and L-selectin targeted DNA vaccines in mice and sheep. |
| Q33840529 | The control of T cell responses by dendritic cell subsets |
| Q82305697 | The delivery of an antigen from the endocytic compartment into the cytosol for cross-presentation is restricted to early immature dendritic cells |
| Q73009798 | The dendritic cell and human cancer vaccines |
| Q47692844 | The distribution of CD1 molecules in inflammatory neuropathy |
| Q40337935 | The dynamic changes of CD3e-CD11c+ dendritic cells in spleens and bone marrow of mice infected with Schistosoma japonicum |
| Q34165325 | The expanding B7 superfamily: increasing complexity in costimulatory signals regulating T cell function |
| Q43508306 | The expression of surface markers on dendritic cells as indicators for the sensitizing potential of chemicals |
| Q36368355 | The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli |
| Q51816597 | The interaction of human dendritic cells with yeast and germ-tube forms of Candida albicans leads to efficient fungal processing, dendritic cell maturation, and acquisition of a Th1 response-promoting function. |
| Q37956385 | The long-term potential of biodegradable poly(lactide-co-glycolide) microparticles as the next-generation vaccine adjuvant |
| Q42663381 | The phosphatidyl-myo-inositol anchor of the lipoarabinomannans from Mycobacterium bovis bacillus Calmette Guérin. Heterogeneity, structure, and role in the regulation of cytokine secretion |
| Q35571920 | The plasmacytoid monocyte/interferon producing cells |
| Q40369714 | The ratio between dendritic cells and T cells determines the outcome of their encounter: proliferation versus deletion |
| Q34255268 | The role of cutaneous dendritic cells in the immunopathogenesis of atopic dermatitis |
| Q73691693 | The selective engulfment of apoptotic bodies by dendritic cells is mediated by the alpha(v)beta3 integrin and requires intracellular and extracellular calcium |
| Q43470518 | The synthetic peptides bovine enteric β-defensin (EBD), bovine neutrophil β-defensin (BNBD) 9 and BNBD 3 are chemotactic for immature bovine dendritic cells |
| Q40675160 | The t-SNARE syntaxin 4 is regulated during macrophage activation to function in membrane traffic and cytokine secretion. |
| Q33533335 | The virion host shut-off (vhs) protein blocks a TLR-independent pathway of herpes simplex virus type 1 recognition in human and mouse dendritic cells |
| Q35531680 | The virion host shutoff protein of herpes simplex virus 1 blocks the replication-independent activation of NF-κB in dendritic cells in the absence of type I interferon signaling. |
| Q38499559 | Therapeutic activity of agonistic monoclonal antibodies against CD40 in a chronic autoimmune inflammatory process |
| Q41633534 | Therapeutic immunization against cancer antigens using genetically engineered cells |
| Q36181313 | Therapeutic potential of dendritic-based vaccines |
| Q44026468 | Therapeutic vaccination against chronic viral infection: the importance of cooperation between CD4+ and CD8+ T cells |
| Q44163620 | Tick saliva inhibits differentiation, maturation and function of murine bone-marrow-derived dendritic cells. |
| Q28079523 | Tolerance in liver transplantation: Biomarkers and clinical relevance |
| Q55469112 | Toll-like receptor triggered dendritic cell maturation and IL-12 secretion are necessary to overcome T-cell inhibition by glioma-associated TGF-beta2. |
| Q34324978 | Towards the rational design of Th1 adjuvants |
| Q37737503 | Tracking dendritic cell migration into lymph nodes by using a novel PET probe 18F-tetrafluoroborate for sodium/iodide symporter |
| Q35605392 | Tracking of dendritic cell migration into lymph nodes using molecular imaging with sodium iodide symporter and enhanced firefly luciferase genes |
| Q80387717 | Transcript profiles of dendritic cells of PLOSL patients link demyelinating CNS disorders with abnormalities in pathways of actin bundling and immune response |
| Q35031987 | Transcriptional regulation of the MHC class II antigen presentation pathway |
| Q43176824 | Transcutaneous immunization with inactivated influenza virus induces protective immune responses |
| Q74445366 | Transduction of CD34+ cells with lentiviral vectors enables the production of large quantities of transgene-expressing immature and mature dendritic cells |
| Q45871048 | Transfected human dendritic cells to induce antitumor immunity |
| Q35966216 | Translational initiation regulated by ATM in dendritic cells development |
| Q36736462 | Translational mini-review series on vaccines: Dendritic cell-based vaccines in renal cancer |
| Q35772684 | Transplantation immunology and the central nervous system |
| Q37712850 | Tricomponent complex loaded with a mosquito-stage antigen of the malaria parasite induces potent transmission-blocking immunity |
| Q35272875 | Tricomponent immunopotentiating system as a novel molecular design strategy for malaria vaccine development |
| Q39511343 | Trypanosoma cruzi infects human dendritic cells and prevents their maturation: inhibition of cytokines, HLA-DR, and costimulatory molecules. |
| Q79445998 | Tumor-derived factors impaired motility and immune functions of dendritic cells through derangement of biophysical characteristics and reorganization of cytoskeleton |
| Q58862665 | Tumour necrosis factor-alpha (TNF-alpha) transgene-expressing dendritic cells (DCs) undergo augmented cellular maturation and induce more robust T-cell activation and anti-tumour immunity than DCs generated in recombinant TNF-alpha |
| Q40678768 | Tumour necrosis factor-alpha but not lipopolysaccharide enhances preference of murine dendritic cells for Th2 differentiation |
| Q51786001 | Two-sided effect of Cordyceps sinensis on dendritic cells in different physiological stages. |
| Q36368488 | Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice. |
| Q52041383 | Unilineage monocytopoiesis in hematopoietic progenitor culture: switching cytokine treatment at all Mo developmental stages induces differentiation into dendritic cells. |
| Q52551661 | Unimpaired dendritic cell functions in MVP/LRP knockout mice. |
| Q56943333 | Upon dendritic cell (DC) activation chemokines and chemokine receptor expression are rapidly regulated for recruitment and maintenance of DC at the inflammatory site |
| Q30636065 | Uptake of the yeast Malassezia furfur and its allergenic components by human immature CD1a+ dendritic cells |
| Q34099008 | Uric acid enhances T cell immune responses to hepatitis B surface antigen-pulsed-dendritic cells in mice |
| Q57005578 | Use of anti-BDCA-2 antibody for detection of dendritic cells type-2 (DC2) in allogeneic hematopoietic stem cell transplantation |
| Q73595155 | Vaccination of chronic myeloid leukemia patients with autologous in vitro cultured leukemic dendritic cells |
| Q36198632 | Vaccines in cancer: GVAX, a GM-CSF gene vaccine |
| Q30306809 | Vagal immune-to-brain communication: a visceral chemosensory pathway |
| Q33351949 | Virus-like particles of SARS-like coronavirus formed by membrane proteins from different origins demonstrate stimulating activity in human dendritic cells |
| Q43981596 | Whole virus influenza vaccine activates dendritic cells (DC) and stimulates cytokine production by peripheral blood mononuclear cells (PBMC) while subunit vaccines support T cell proliferation. |
| Q53787542 | [Genetic immunization: new ways for protective and therapeutic vaccines against allergic diseases]. |
| Q88009436 | miR-155 deficiency protects mice from experimental colitis by reducing T helper type 1/type 17 responses |
| Q34646735 | p38 Mitogen-Activated Protein Kinase in beryllium-induced dendritic cell activation |
| Q43822750 | p38-Dependent marking of inflammatory genes for increased NF-kappa B recruitment |
Search more.